| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-08-28 | 2009-06-30 | N-Q | Alkermes Inc | ALKS | US | Drug Delivery Systems | 717,147 | Sold Some | -50,602 | -6.59 % | $6,719,667 | $6,210,493 | $-509,174 | -7.57 % | $35,927 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Alkermes Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Akorn Inc | AKRX | US | Medical-Drugs | 851,817 | Sold Some | -41,112 | -4.60 % | $1,098,844 | $1,371,425 | $272,581 | 24.80 % | $-13,156 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Akorn Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Enzon Pharmaceuticals Inc | ENZN | US | Medical-Biomedical/Gene | 518,174 | Sold Some | -15,468 | -2.89 % | $3,725,671 | $5,347,556 | $1,621,885 | 43.53 % | $-48,415 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Synta Pharmaceuticals Corp | SNTA | US | Medical-Drugs | 128,993 | Sold Some | -6,228 | -4.60 % | $383,109 | $492,753 | $109,644 | 28.61 % | $-5,294 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Synta Pharmaceuticals Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Amag Pharmaceuticals Inc | AMAG | BE | Medical-Biomedical/Gene | 154,079 | Sold Some | -8,669 | -5.32 % | $6,374,248 | $6,124,640 | $-249,608 | -3.91 % | $14,044 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Illumina Inc | ILMN | US | Medical-Biomedical/Gene | 979,129 | Sold Some | -37,696 | -3.70 % | $34,514,297 | $26,250,448 | $-8,263,849 | -23.94 % | $318,154 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Illumina Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Immunogen Inc | IMGN | US | Medical-Biomedical/Gene | 359,888 | Sold Some | -4,556 | -1.25 % | $2,609,188 | $3,005,065 | $395,877 | 15.17 % | $-5,012 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Immunogen Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Incyte Corp Ltd | INCY | US | Medical-Biomedical/Gene | 975,835 | Sold Some | -45,633 | -4.46 % | $6,596,645 | $7,367,554 | $770,910 | 11.68 % | $-36,050 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Incyte Corp Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Genomic Health Inc | GHDX | US | Medical-Biomedical/Gene | 268,218 | Sold Some | -7,543 | -2.73 % | $5,375,089 | $5,173,925 | $-201,164 | -3.74 % | $5,657 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Genomic Health Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Maxygen Inc | MAXY | US | Medical-Biomedical/Gene | 313,896 | Sold Some | -15,121 | -4.59 % | $2,143,910 | $1,764,096 | $-379,814 | -17.71 % | $18,296 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Maxygen Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Middlebrook Pharmaceuticals Inc | MBRK | US | Medical-Drugs | 240,222 | Sold Some | -11,592 | -4.60 % | $271,451 | $163,351 | $-108,100 | -39.82 % | $5,216 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Middlebrook Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Isis Pharmaceuticals Inc | ISIS | US | Therapeutics | 835,965 | Sold Some | -44,222 | -5.02 % | $13,500,835 | $9,387,887 | $-4,112,948 | -30.46 % | $217,572 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Isis Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Lexicon Pharmaceuticals Inc | LXRX | US | Medical-Biomedical/Gene | 1,142,061 | Sold Some | -55,116 | -4.60 % | $1,701,671 | $1,713,092 | $11,421 | 0.67 % | $-551 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Lexicon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Dyax Corp | DYAX | US | Therapeutics | 678,727 | Sold Some | -32,760 | -4.60 % | $2,463,779 | $2,653,823 | $190,044 | 7.71 % | $-9,173 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Dyax Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Geron Corp | GERN | US | Medical-Biomedical/Gene | 991,117 | Sold Some | -40,902 | -3.96 % | $7,116,220 | $5,530,433 | $-1,585,787 | -22.28 % | $65,443 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Geron Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Genvec Inc | GNVC | US | Medical-Biomedical/Gene | 0 | Sold All | -689,057 | -100 % | - | - | - | 15.78 % | $-82,687 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Genvec Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Gtx Inc | GTXI | US | Medical-Biomedical/Gene | 339,925 | Sold Some | -8,433 | -2.42 % | $3,198,694 | $1,193,137 | $-2,005,558 | -62.69 % | $49,755 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Gtx Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Halozyme Therapeutics Inc | HALO | US | Medical-Biomedical/Gene | 757,550 | Sold Some | -39,928 | -5.00 % | $5,658,899 | $4,825,594 | $-833,305 | -14.72 % | $43,921 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Harvard Bioscience Inc | HBIO | US | Medical-Biomedical/Gene | 0 | Sold All | -252,588 | -100 % | - | - | - | 4.58 % | $-40,414 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Harvard Bioscience Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Human Genome Sciences Inc | HGSI | US | Medical-Biomedical/Gene | 649,058 | Sold Some | -31,320 | -4.60 % | $12,851,348 | $17,771,208 | $4,919,860 | 38.28 % | $-237,406 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Combinatorx Inc | CRXX | US | Medical-Drugs | 0 | Sold All | -327,575 | -100 % | - | - | - | -17.69 % | $75,342 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Combinatorx Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Cv Therapeutics Inc | CVTX | US | Therapeutics | 0 | Sold All | -794,507 | -100 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cv Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Cadence Pharmaceuticals Inc | CADX | US | Medical-Drugs | 369,779 | Added More | 7,732 | 2.13 % | $4,008,404 | $3,217,077 | $-791,327 | -19.74 % | $-16,546 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Columbia Laboratories Inc | CBRX | US | Feminine Health Care Prd | 452,760 | Sold Some | -21,852 | -4.60 % | $547,840 | $430,122 | $-117,718 | -21.48 % | $5,682 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Columbia Laboratories Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Cell Genesys Inc | CEGE | US | Medical-Biomedical/Gene | 0 | Sold All | -974,295 | -100 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cell Genesys Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Cytokinetics Inc | CYTK | US | Medical-Biomedical/Gene | 495,078 | Sold Some | -23,886 | -4.60 % | $1,505,037 | $1,683,265 | $178,228 | 11.84 % | $-8,599 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cytokinetics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Discovery Laboratories Inc | DSCO | US | Therapeutics | 975,768 | Added More | 58,778 | 6.40 % | $478,126 | $712,311 | $234,184 | 48.97 % | $14,107 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Discovery Laboratories Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Durect Corp | DRRX | US | Medical-Drugs | 725,317 | Sold Some | -34,962 | -4.59 % | $1,827,799 | $1,515,913 | $-311,886 | -17.06 % | $15,034 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Durect Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Vivus Inc | VVUS | US | Therapeutics | 501,544 | Sold Some | -17,648 | -3.39 % | $3,164,743 | $4,223,000 | $1,058,258 | 33.43 % | $-37,237 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Vivus Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Altus Pharmaceuticals Inc | ALTU | US | Therapeutics | 0 | Sold All | -292,523 | -100 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Altus Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 749,975 | Sold Some | -38,821 | -4.92 % | $33,486,384 | $32,773,908 | $-712,476 | -2.12 % | $36,880 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Albany Molecular Research Inc | AMRI | US | Research And Development | 344,730 | Sold Some | -16,632 | -4.60 % | $2,833,681 | $2,861,259 | $27,578 | 0.97 % | $-1,331 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Albany Molecular Research Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ariad Pharmaceuticals Inc | ARIA | US | Medical-Biomedical/Gene | 705,805 | Sold Some | -34,056 | -4.60 % | $1,559,829 | $1,524,539 | $-35,290 | -2.26 % | $1,703 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Ariad Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Array Biopharma Inc | ARRY | US | Medical-Drugs | 322,988 | Sold Some | -15,588 | -4.60 % | $1,350,090 | $655,666 | $-694,424 | -51.43 % | $33,514 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Array Biopharma Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Acadia Pharmaceuticals Inc | ACAD | US | Medical-Drugs | 0 | Sold All | -359,036 | -100 % | - | - | - | -77.75 % | $1,669,517 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Acorda Therapeutics Inc | ACOR | US | Medical-Biomedical/Gene | 331,241 | Sold Some | -12,234 | -3.56 % | $7,512,546 | $7,916,660 | $404,114 | 5.37 % | $-14,925 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Acorda Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Adolor Corp | ADLR | US | Medical-Drugs | 685,368 | Sold Some | -33,114 | -4.60 % | $1,130,857 | $1,034,906 | $-95,952 | -8.48 % | $4,636 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Adolor Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Cephalon Inc | CEPH | US | Medical-Drugs | 296,155 | Added More | 3,021 | 1.03 % | $16,652,796 | $17,653,800 | $1,001,004 | 6.01 % | $10,211 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cephalon Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Cerus Corp | CERS | US | Medical Products | 0 | Sold All | -306,967 | -100 % | - | - | - | -6.10 % | $39,906 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cerus Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 365,345 | Sold Some | -18,832 | -4.90 % | $10,317,343 | $12,761,501 | $2,444,158 | 23.68 % | $-125,986 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Avi Biopharma Inc | AVII | US | Therapeutics | 0 | Sold All | -683,880 | -100 % | - | - | - | 0.68 % | $-6,839 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Avi Biopharma Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Biomarin Pharmaceutical Inc | BMRN | US | Therapeutics | 1,053,867 | Sold Some | -68,706 | -6.12 % | $17,357,189 | $17,884,123 | $526,934 | 3.03 % | $-34,353 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Biomimetic Therapeutics Inc | BMTI | US | Medical-Biomedical/Gene | 184,486 | Sold Some | -8,910 | -4.60 % | $2,164,021 | $2,047,795 | $-116,226 | -5.37 % | $5,613 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biomimetic Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Cardiome Pharma Corp | CRME | CA | Medical-Drugs | 519,684 | Sold Some | -25,074 | -4.60 % | $2,317,791 | $1,938,421 | $-379,369 | -16.36 % | $18,304 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cardiome Pharma Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Pozen Inc | POZN | US | Medical-Drugs | 294,913 | Sold Some | -14,238 | -4.60 % | $1,908,087 | $2,049,645 | $141,558 | 7.41 % | $-6,834 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Pozen Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Alnylam Pharmaceuticals Inc | ALNY | US | Therapeutics | 370,735 | Sold Some | -22,102 | -5.62 % | $8,323,001 | $6,243,177 | $-2,079,823 | -24.98 % | $123,992 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Allos Therapeutics Inc | ALTH | US | Therapeutics | 750,830 | Added More | 9,653 | 1.30 % | $5,616,208 | $4,625,113 | $-991,096 | -17.64 % | $-12,742 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Allos Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Mylan Incpa | MYL | US | Medical-Generic Drugs | 1,865,783 | New Holding | 1,865,783 | 100 % | $27,613,588 | $32,744,492 | $5,130,903 | 18.58 % | $5,130,903 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Mylan Incpa |
| 2009-08-28 | 2009-06-30 | N-Q | Arqule Inc | ARQL | US | Medical-Biomedical/Gene | 329,082 | Sold Some | -15,876 | -4.60 % | $1,823,114 | $1,085,971 | $-737,144 | -40.43 % | $35,562 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Arqule Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Questcor Pharmaceuticals Inc | QSC | US | Therapeutics | 557,308 | New Holding | 557,308 | 100 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Questcor Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Alexza Pharmaceuticals Inc | ALXA | US | Therapeutics | 293,541 | Sold Some | -14,166 | -4.60 % | $792,561 | $669,273 | $-123,287 | -15.55 % | $5,950 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Alexza Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Qiagen Nv | QGEN | DE | Medical-Biomedical/Gene | 1,042,626 | Sold Some | -51,315 | -4.69 % | $21,394,686 | $22,426,885 | $1,032,200 | 4.82 % | $-50,802 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Qiagen Nv |
| 2009-08-28 | 2009-06-30 | N-Q | Luminex Corp | LMNX | US | Medical Products | 364,886 | Sold Some | -24,272 | -6.23 % | $5,641,138 | $5,079,213 | $-561,924 | -9.96 % | $37,379 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Luminex Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Telik Inc | TELK | US | Medical-Biomedical/Gene | 0 | Sold All | -552,817 | -100 % | - | - | - | -13.33 % | $66,338 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Telik Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Theravance Inc | THRX | US | Therapeutics | 500,318 | Sold Some | -25,237 | -4.80 % | $7,875,005 | $7,024,465 | $-850,541 | -10.80 % | $42,903 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Theravance Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Micromet Inc | MITI | DE | Medical-Biomedical/Gene | 112,760 | Added More | 12,438 | 12.39 % | $746,471 | $778,044 | $31,573 | 4.22 % | $3,483 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Micromet Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 607,595 | Added More | 17,617 | 2.98 % | $9,363,039 | $6,555,950 | $-2,807,089 | -29.98 % | $-81,391 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Intermune Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Zymogenetics Inc | ZGEN | US | Medical-Drugs | 739,303 | Sold Some | -35,676 | -4.60 % | $4,324,923 | $4,376,674 | $51,751 | 1.19 % | $-2,497 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Zymogenetics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Depomed Inc | DEPO | US | Drug Delivery Systems | 512,980 | Sold Some | -24,750 | -4.60 % | $1,590,238 | $1,692,834 | $102,596 | 6.45 % | $-4,950 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Depomed Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Pharmasset Inc | VRUS | US | Medical-Drugs | 554,864 | Sold Some | -19,574 | -3.40 % | $10,048,587 | $10,908,626 | $860,039 | 8.55 % | $-30,340 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Pharmasset Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Xenoport Inc | XNPT | US | Medical-Drugs | 244,269 | Sold Some | -13,855 | -5.36 % | $4,343,103 | $3,993,798 | $-349,305 | -8.04 % | $19,813 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Xenoport Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Xoma Ltd | XOMA | US | Medical-Biomedical/Gene | 1,782,692 | Sold Some | -86,022 | -4.60 % | $1,533,115 | $1,319,192 | $-213,923 | -13.95 % | $10,323 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Xoma Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Biocryst Pharmaceuticals Inc | BCRX | US | Medical-Biomedical/Gene | 334,145 | Sold Some | -16,128 | -4.60 % | $4,203,544 | $3,191,085 | $-1,012,459 | -24.08 % | $48,868 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Biodel Inc | BIOD | US | Medical-Drugs | 221,109 | Sold Some | -10,674 | -4.60 % | $1,114,389 | $917,602 | $-196,787 | -17.65 % | $9,500 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biodel Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sequenom Inc | SQNM | US | Medical-Biomedical/Gene | 551,665 | Sold Some | -33,102 | -5.66 % | $2,912,791 | $1,726,711 | $-1,186,080 | -40.71 % | $71,169 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Sequenom Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Stemcells Inc | STEM | US | Medical-Biomedical/Gene | 944,027 | Added More | 94,216 | 11.08 % | $1,538,764 | $1,028,989 | $-509,775 | -33.12 % | $-50,877 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Stemcells Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Supergen Inc | SUPG | US | Medical-Biomedical/Gene | 524,442 | Sold Some | -25,308 | -4.60 % | $1,499,904 | $1,426,482 | $-73,422 | -4.89 % | $3,543 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Supergen Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Rigel Pharmaceuticals Inc | RIGL | US | Medical-Drugs | 348,814 | Sold Some | -16,830 | -4.60 % | $2,539,366 | $2,713,773 | $174,407 | 6.86 % | $-8,415 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Vanda Pharmaceuticals Inc | VNDA | US | Therapeutics | 0 | Sold All | -167,651 | -100 % | - | - | - | -26.78 % | $630,368 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Vanda Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Trimeris Inc | TRMS | US | Therapeutics | 0 | Sold All | -292,935 | -100 % | - | - | - | 32.79 % | $-237,277 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Trimeris Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Salix Pharmaceuticals Ltd | SLXP | US | Medical-Drugs | 467,660 | Sold Some | -18,310 | -3.76 % | $5,869,133 | $10,947,921 | $5,078,788 | 86.53 % | $-198,847 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Progenics Pharmaceuticals Inc | PGNX | US | Therapeutics | 303,079 | Sold Some | -14,632 | -4.60 % | $1,618,442 | $1,233,532 | $-384,910 | -23.78 % | $18,583 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Novavax Inc | NVAX | US | Medical-Biomedical/Gene | 773,825 | Added More | 102,394 | 15.25 % | $4,557,829 | $2,538,146 | $-2,019,683 | -44.31 % | $-267,248 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Novavax Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seattle Genetics Inc | SGEN | US | Medical-Biomedical/Gene | 721,845 | Sold Some | -9,538 | -1.30 % | $8,799,291 | $6,713,159 | $-2,086,132 | -23.70 % | $27,565 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Seattle Genetics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sangamo Biosciences Inc | SGMO | US | Medical-Biomedical/Gene | 398,888 | Sold Some | -19,242 | -4.60 % | $2,824,127 | $2,197,873 | $-626,254 | -22.17 % | $30,210 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Sangamo Biosciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Pain Therapeutics Inc | PTIE | US | Medical-Drugs | 308,318 | Sold Some | -14,886 | -4.60 % | $1,590,921 | $1,464,511 | $-126,410 | -7.94 % | $6,103 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Pain Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Regeneron Pharmaceuticals Inc | REGN | US | Medical-Biomedical/Gene | 1,000,329 | Sold Some | -59,006 | -5.57 % | $22,337,347 | $18,466,073 | $-3,871,273 | -17.33 % | $228,353 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Regeneron Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 679,976 | Sold Some | -41,334 | -5.73 % | $21,460,043 | $19,032,528 | $-2,427,514 | -11.31 % | $147,562 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Optimer Pharmaceuticals Inc | OPTR | US | Medical-Biomedical/Gene | 269,231 | Added More | 12,413 | 4.83 % | $3,529,618 | $3,230,772 | $-298,846 | -8.46 % | $-13,778 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Optimer Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Orexigen Therapeutics Inc | OREX | US | Medical-Biomedical/Gene | 309,484 | Sold Some | -14,940 | -4.60 % | $2,516,105 | $2,126,155 | $-389,950 | -15.49 % | $18,824 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Orexigen Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Osiris Therapeutics Inc | OSIR | US | Therapeutics | 304,117 | Sold Some | -11,417 | -3.61 % | $4,382,326 | $1,998,049 | $-2,384,277 | -54.40 % | $89,509 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Osiris Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Medarex Inc | MEDX | US | Therapeutics | 1,555,108 | Sold Some | -95,870 | -5.80 % | $24,835,075 | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Medarex Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Monogram Biosciences Inc | MGRM | US | Medical-Biomedical/Gene | 0 | Sold All | -221,315 | -100 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Monogram Biosciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Momenta Pharmaceuticals Inc | MNTA | US | Medical-Biomedical/Gene | 370,098 | Sold Some | -15,095 | -3.91 % | $3,671,372 | $4,089,583 | $418,211 | 11.39 % | $-17,057 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Momenta Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Dendreon Corp | DNDN | US | Therapeutics | 1,009,386 | Added More | 111,809 | 12.45 % | $24,003,199 | $28,272,902 | $4,269,703 | 17.78 % | $472,952 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Dendreon Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Immunomedics Inc | IMMU | US | Medical-Biomedical/Gene | 757,732 | Sold Some | -36,558 | -4.60 % | $4,372,114 | $2,689,949 | $-1,682,165 | -38.47 % | $81,159 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Immunomedics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Nabi Biopharmaceuticals | NABI | US | Therapeutics | 655,236 | Sold Some | -31,626 | -4.60 % | $2,031,232 | $3,210,656 | $1,179,425 | 58.06 % | $-56,927 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | N-Q | Endo Pharmaceuticals Holdings Inc | ENDP | US | Medical-Drugs | 495,341 | Sold Some | -32,286 | -6.11 % | $11,264,054 | $10,996,570 | $-267,484 | -2.37 % | $17,434 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Gen-Probe Inc | GPRO | US | Diagnostic Equipment | 308,625 | Sold Some | -23,781 | -7.15 % | $12,036,375 | $12,872,749 | $836,374 | 6.94 % | $-64,447 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Gen-Probe Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Nektar Therapeutics | NKTR | US | Medical-Biomedical/Gene | 1,008,760 | Sold Some | -53,860 | -5.06 % | $8,221,394 | $8,715,686 | $494,292 | 6.01 % | $-26,391 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Nektar Therapeutics |
| 2009-08-28 | 2009-06-30 | N-Q | Osi Pharmaceuticals Inc | OSIP | US | Medical-Drugs | 454,503 | Sold Some | -28,618 | -5.92 % | $15,521,277 | $14,903,153 | $-618,124 | -3.98 % | $38,920 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Osi Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Pdl Biopharma Inc | PDLI | US | Medical-Biomedical/Gene | 802,961 | Sold Some | -884,149 | -52.40 % | $7,274,827 | $6,343,392 | $-931,435 | -12.80 % | $1,025,613 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Pdl Biopharma Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Matrixx Initiatives Inc | MTXX | US | Drug Delivery Systems | 88,436 | Added More | 9,864 | 12.55 % | $468,711 | $373,200 | $-95,511 | -20.37 % | $-10,653 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Matrixx Initiatives Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Medicines Cothe | MDCO | US | Therapeutics | 330,846 | Sold Some | -19,543 | -5.57 % | $2,504,504 | $2,474,728 | $-29,776 | -1.18 % | $1,759 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Medicines Cothe |
| 2009-08-28 | 2009-06-30 | N-Q | Sepracor Inc | SEPR | US | Medical-Drugs | 467,026 | Sold Some | -24,664 | -5.01 % | $8,682,013 | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Sepracor Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Perrigo Co | PRGO | IL | Medical-Generic Drugs | 789,094 | Sold Some | -873,792 | -52.54 % | $23,483,437 | $31,019,285 | $7,535,848 | 32.09 % | $-8,344,714 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Perrigo Co |
| 2009-08-28 | 2009-06-30 | N-Q | Neurocrine Biosciences Inc | NBIX | US | Therapeutics | 228,727 | Sold Some | -11,034 | -4.60 % | $702,192 | $487,189 | $-215,003 | -30.61 % | $10,372 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Neurocrine Biosciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Noven Pharmaceuticals Inc | NOVN | US | Drug Delivery Systems | 182,768 | Sold Some | -1,140 | -0.61 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Noven Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Amylin Pharmaceuticals Inc | AMLN | US | Therapeutics | 576,048 | Sold Some | -24,416 | -4.06 % | $7,436,780 | $7,166,037 | $-270,743 | -3.64 % | $11,476 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 1,751,547 | Sold Some | -101,369 | -5.47 % | $92,341,558 | $96,177,446 | $3,835,888 | 4.15 % | $-221,998 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Celgene Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 819,174 | Sold Some | -56,492 | -6.45 % | $45,488,732 | $40,999,659 | $-4,489,074 | -9.86 % | $309,576 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Genzyme Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Gilead Sciences Inc | GILD | US | Therapeutics | 2,740,013 | Sold Some | -173,984 | -5.97 % | $123,985,588 | $127,109,203 | $3,123,615 | 2.51 % | $-198,342 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Gilead Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 789,375 | Sold Some | -26,729 | -3.27 % | $24,202,238 | $18,629,250 | $-5,572,988 | -23.02 % | $188,707 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Myriad Genetics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | United Therapeutics Corp | UTHR | US | Therapeutics | 266,852 | Sold Some | -13,824 | -4.92 % | $24,582,406 | $11,984,323 | $-12,598,083 | -51.24 % | $652,631 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of United Therapeutics Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Impax Laboratories Inc | IPXL.PK | US | Medical-Generic Drugs | 514,744 | New Holding | 514,744 | 100 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Impax Laboratories Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Arena Pharmaceuticals Inc | ARNA | US | Medical-Biomedical/Gene | 550,462 | Added More | 258 | 0.04 % | $2,587,171 | $1,932,122 | $-655,050 | -25.31 % | $-307 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Arena Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Inspire Pharmaceuticals Inc | ISPH | US | Therapeutics | 809,446 | Sold Some | -39,060 | -4.60 % | $4,961,904 | $4,079,608 | $-882,296 | -17.78 % | $42,575 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Inspire Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Savient Pharmaceuticals Inc | SVNT | US | Medical-Biomedical/Gene | 496,567 | Added More | 11,964 | 2.46 % | $6,812,899 | $6,857,590 | $44,691 | 0.65 % | $1,077 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Savient Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Caliper Life Sciences Inc | CALP | US | Medical Products | 0 | Sold All | -424,745 | -100 % | - | - | - | 47.54 % | $-369,528 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Caliper Life Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Idenix Pharmaceuticals Inc | IDIX | US | Medical-Drugs | 504,201 | Sold Some | -24,336 | -4.60 % | $1,593,275 | $927,730 | $-665,545 | -41.77 % | $32,124 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Idenix Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Angiotech Pharmaceuticals Inc | ANPI | CA | Medical-Drugs | 0 | Sold All | -412,572 | -100 % | - | - | - | -23.07 % | $160,903 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Angiotech Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Qlt Inc | QLTI | CA | Therapeutics | 631,692 | Sold Some | -30,475 | -4.60 % | $2,678,374 | $2,330,943 | $-347,431 | -12.97 % | $16,761 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Qlt Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Vertex Pharmaceuticals Inc | VRTX | US | Medical-Biomedical/Gene | 1,446,196 | Sold Some | -25,688 | -1.74 % | $54,000,959 | $55,736,394 | $1,735,435 | 3.21 % | $-30,826 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Viropharma Inc | VPHM | US | Medical-Drugs | 663,711 | Sold Some | -30,965 | -4.45 % | $5,389,333 | $5,110,575 | $-278,759 | -5.17 % | $13,005 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Viropharma Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Techne Corp | TECH | US | Medical Instruments | 211,473 | Sold Some | -16,909 | -7.40 % | $13,066,917 | $14,194,068 | $1,127,151 | 8.62 % | $-90,125 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Techne Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Exelixis Inc | EXEL | US | Medical-Biomedical/Gene | 1,237,026 | Sold Some | -53,142 | -4.11 % | $7,063,418 | $8,300,444 | $1,237,026 | 17.51 % | $-53,142 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Exelixis Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Cubist Pharmaceuticals Inc | CBST | US | Medical-Drugs | 593,981 | Sold Some | -32,741 | -5.22 % | $12,491,420 | $10,067,978 | $-2,423,442 | -19.40 % | $133,583 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cubist Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 968,162 | Sold Some | -89,251 | -8.44 % | $48,340,329 | $44,903,354 | $-3,436,975 | -7.10 % | $316,841 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biogen Idec Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Mannkind Corp | MNKD | US | Therapeutics | 1,030,294 | Sold Some | -96,665 | -8.57 % | $8,170,231 | $7,088,423 | $-1,081,809 | -13.24 % | $101,498 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Mannkind Corp |
| 2009-08-28 | 2009-06-30 | N-Q | Santarus Inc | SNTS | US | Medical-Drugs | 508,017 | Sold Some | -24,516 | -4.60 % | $1,625,654 | $2,032,068 | $406,414 | 25.00 % | $-19,613 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Santarus Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Affymetrix Inc | AFFX | US | Medical-Biomedical/Gene | 544,881 | Added More | 11,813 | 2.21 % | $4,440,780 | $2,637,224 | $-1,803,556 | -40.61 % | $-39,101 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Affymetrix Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Shire Plc | SHPGY | DE | Medical-Drugs | 0 | Sold All | -933,532 | -100 % | - | - | - | 13.13 % | $-6,114,635 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Shire Plc |
| 2009-08-28 | 2009-06-30 | N-Q | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 2,773,492 | Sold Some | -222,628 | -7.43 % | $165,327,858 | $153,595,987 | $-11,731,871 | -7.09 % | $941,716 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Amgen Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Medivation Inc | MDVN | US | Medical-Biomedical/Gene | 273,292 | Sold Some | -8,332 | -2.95 % | $6,821,368 | $7,985,592 | $1,164,224 | 17.06 % | $-35,494 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Medivation Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Biodel Inc | BIOD | US | Medical-Drugs | 231,783 | Sold Some | -15,418 | -6.23 % | $1,158,915 | $961,899 | $-197,016 | -17.00 % | $13,105 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biodel Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Enzon Pharmaceuticals Inc | ENZN | US | Medical-Biomedical/Gene | 533,642 | Sold Some | -49,298 | -8.45 % | $4,141,062 | $5,507,185 | $1,366,124 | 32.98 % | $-126,203 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Sepracor Inc | SEPR | US | Medical-Drugs | 491,690 | Sold Some | -35,070 | -6.65 % | $8,058,799 | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Sepracor Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Synta Pharmaceuticals Corp | SNTA | US | Medical-Drugs | 135,221 | Sold Some | -8,996 | -6.23 % | $352,927 | $516,544 | $163,617 | 46.36 % | $-10,885 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Synta Pharmaceuticals Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Sequenom Inc | SQNM | US | Medical-Biomedical/Gene | 584,767 | Sold Some | -49,619 | -7.82 % | $2,064,228 | $1,830,321 | $-233,907 | -11.33 % | $19,848 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Sequenom Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Amag Pharmaceuticals Inc | AMAG | BE | Medical-Biomedical/Gene | 162,748 | Sold Some | -10,816 | -6.23 % | $8,860,001 | $6,469,233 | $-2,390,768 | -26.98 % | $158,887 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Angiotech Pharmaceuticals Inc | ANPI | CA | Medical-Drugs | 412,572 | Sold Some | -27,430 | -6.23 % | $701,372 | $536,344 | $-165,029 | -23.52 % | $10,972 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Angiotech Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Indevus Pharmaceuticals Inc | IDEV | US | Medical-Drugs | 0 | Sold All | -672,234 | -100 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Indevus Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Illumina Inc | ILMN | US | Medical-Biomedical/Gene | 1,016,825 | Sold Some | -107,250 | -9.54 % | $39,371,464 | $27,261,078 | $-12,110,386 | -30.75 % | $1,277,348 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Illumina Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Stemcells Inc | STEM | US | Medical-Biomedical/Gene | 849,811 | Added More | 37,223 | 4.58 % | $1,487,169 | $926,294 | $-560,875 | -37.71 % | $-24,567 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Stemcells Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Immunogen Inc | IMGN | US | Medical-Biomedical/Gene | 364,444 | Sold Some | -43,207 | -10.59 % | $3,057,685 | $3,043,107 | $-14,578 | -0.47 % | $1,728 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Immunogen Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Perrigo Co | PRGO | IL | Medical-Generic Drugs | 1,662,886 | Added More | 761,993 | 84.58 % | $43,883,562 | $65,368,049 | $21,484,487 | 48.95 % | $9,844,950 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Perrigo Co |
| 2009-06-05 | 2009-03-31 | N-CSR | Incyte Corp Ltd | INCY | US | Medical-Biomedical/Gene | 1,021,468 | Sold Some | -91,080 | -8.18 % | $3,922,437 | $7,712,083 | $3,789,646 | 96.61 % | $-337,907 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Incyte Corp Ltd |
| 2009-06-05 | 2009-03-31 | N-CSR | Supergen Inc | SUPG | US | Medical-Biomedical/Gene | 549,750 | Sold Some | -36,556 | -6.23 % | $1,094,003 | $1,495,320 | $401,318 | 36.68 % | $-26,686 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Supergen Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Genomic Health Inc | GHDX | US | Medical-Biomedical/Gene | 275,761 | Sold Some | -23,984 | -8.00 % | $4,963,698 | $5,319,430 | $355,732 | 7.16 % | $-30,939 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Genomic Health Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Mannkind Corp | MNKD | US | Therapeutics | 1,126,959 | Sold Some | -74,932 | -6.23 % | $7,956,331 | $7,753,478 | $-202,853 | -2.54 % | $13,488 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Mannkind Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Maxygen Inc | MAXY | US | Medical-Biomedical/Gene | 329,017 | Sold Some | -49,457 | -13.06 % | $2,378,793 | $1,849,076 | $-529,717 | -22.26 % | $79,626 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Maxygen Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Rigel Pharmaceuticals Inc | RIGL | US | Medical-Drugs | 365,644 | Sold Some | -38,048 | -9.42 % | $3,608,906 | $2,844,710 | $-764,196 | -21.17 % | $79,520 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Middlebrook Pharmaceuticals Inc | MBRK | US | Medical-Drugs | 251,814 | New Holding | 251,814 | 100 % | $395,348 | $171,234 | $-224,114 | -56.68 % | $-224,114 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Middlebrook Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Neurocrine Biosciences Inc | NBIX | US | Therapeutics | 239,761 | Sold Some | -15,938 | -6.23 % | $800,802 | $510,691 | $-290,111 | -36.22 % | $19,285 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Neurocrine Biosciences Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Isis Pharmaceuticals Inc | ISIS | US | Therapeutics | 880,187 | Sold Some | -63,353 | -6.71 % | $13,317,229 | $9,884,500 | $-3,432,729 | -25.77 % | $247,077 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Isis Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Vanda Pharmaceuticals Inc | VNDA | US | Therapeutics | 167,651 | Sold Some | -11,154 | -6.23 % | $2,162,698 | $1,723,452 | $-439,246 | -20.31 % | $29,223 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Vanda Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Lexicon Pharmaceuticals Inc | LXRX | US | Medical-Biomedical/Gene | 1,197,177 | Sold Some | -79,612 | -6.23 % | $1,664,076 | $1,795,766 | $131,689 | 7.91 % | $-8,757 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Lexicon Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Qlt Inc | QLTI | CA | Therapeutics | 662,167 | Sold Some | -60,405 | -8.35 % | $1,582,579 | $2,443,396 | $860,817 | 54.39 % | $-78,527 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Qlt Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Dyax Corp | DYAX | US | Therapeutics | 711,487 | Sold Some | -47,320 | -6.23 % | $1,330,481 | $2,781,914 | $1,451,433 | 109.09 % | $-96,533 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Dyax Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Trimeris Inc | TRMS | US | Therapeutics | 292,935 | Sold Some | -19,474 | -6.23 % | $632,740 | $960,827 | $328,087 | 51.85 % | $-21,811 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Trimeris Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Geron Corp | GERN | US | Medical-Biomedical/Gene | 1,032,019 | Added More | 37,169 | 3.73 % | $7,048,690 | $5,758,666 | $-1,290,024 | -18.30 % | $-46,461 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Geron Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Noven Pharmaceuticals Inc | NOVN | US | Drug Delivery Systems | 183,908 | Sold Some | -20,605 | -10.07 % | $2,137,011 | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Noven Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Genvec Inc | GNVC | US | Medical-Biomedical/Gene | 689,057 | Sold Some | -45,812 | -6.23 % | $565,027 | $606,370 | $41,343 | 7.31 % | $-2,749 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Genvec Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Salix Pharmaceuticals Ltd | SLXP | US | Medical-Drugs | 485,970 | Sold Some | -40,812 | -7.74 % | $5,306,792 | $11,376,558 | $6,069,765 | 114.37 % | $-509,742 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-06-05 | 2009-03-31 | N-CSR | Gtx Inc | GTXI | US | Medical-Biomedical/Gene | 348,358 | Sold Some | -31,237 | -8.22 % | $3,065,550 | $1,222,737 | $-1,842,814 | -60.11 % | $165,244 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Gtx Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 2,996,120 | Sold Some | -321,569 | -9.69 % | $152,472,547 | $165,925,126 | $13,452,579 | 8.82 % | $-1,443,845 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Amgen Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Halozyme Therapeutics Inc | HALO | US | Medical-Biomedical/Gene | 797,478 | Sold Some | -53,040 | -6.23 % | $6,260,202 | $5,079,935 | $-1,180,267 | -18.85 % | $78,499 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Progenics Pharmaceuticals Inc | PGNX | US | Therapeutics | 317,711 | Sold Some | -21,138 | -6.23 % | $1,836,370 | $1,293,084 | $-543,286 | -29.58 % | $36,146 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Harvard Bioscience Inc | HBIO | US | Medical-Biomedical/Gene | 252,588 | Sold Some | -16,796 | -6.23 % | $868,903 | $921,946 | $53,043 | 6.10 % | $-3,527 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Harvard Bioscience Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Amylin Pharmaceuticals Inc | AMLN | US | Therapeutics | 600,464 | Sold Some | -47,727 | -7.36 % | $6,665,150 | $7,469,772 | $804,622 | 12.07 % | $-63,954 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Human Genome Sciences Inc | HGSI | US | Medical-Biomedical/Gene | 680,378 | Sold Some | -45,240 | -6.23 % | $1,918,666 | $18,628,750 | $16,710,084 | 870.92 % | $-1,111,094 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Novavax Inc | NVAX | US | Medical-Biomedical/Gene | 671,431 | Sold Some | -44,642 | -6.23 % | $1,745,721 | $2,202,294 | $456,573 | 26.15 % | $-30,357 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Novavax Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Combinatorx Inc | CRXX | US | Medical-Drugs | 327,575 | Sold Some | -21,788 | -6.23 % | $268,612 | $350,505 | $81,894 | 30.48 % | $-5,447 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Combinatorx Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Vertex Pharmaceuticals Inc | VRTX | US | Medical-Biomedical/Gene | 1,471,884 | Added More | 36,835 | 2.56 % | $45,304,590 | $56,726,409 | $11,421,820 | 25.21 % | $285,840 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Cv Therapeutics Inc | CVTX | US | Therapeutics | 794,507 | Sold Some | -20,749 | -2.54 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cv Therapeutics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Seattle Genetics Inc | SGEN | US | Medical-Biomedical/Gene | 731,383 | Sold Some | -27,027 | -3.56 % | $7,562,500 | $6,801,862 | $-760,638 | -10.05 % | $28,108 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Seattle Genetics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Cadence Pharmaceuticals Inc | CADX | US | Medical-Drugs | 362,047 | Sold Some | -21,672 | -5.64 % | $3,736,325 | $3,149,809 | $-586,516 | -15.69 % | $35,109 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 1,852,916 | Sold Some | -140,883 | -7.06 % | $82,176,825 | $101,743,618 | $19,566,793 | 23.81 % | $-1,487,724 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Celgene Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Columbia Laboratories Inc | CBRX | US | Feminine Health Care Prd | 474,612 | Sold Some | -31,564 | -6.23 % | $574,281 | $450,881 | $-123,399 | -21.48 % | $8,207 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Columbia Laboratories Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Sangamo Biosciences Inc | SGMO | US | Medical-Biomedical/Gene | 418,130 | Sold Some | -34,470 | -7.61 % | $1,764,509 | $2,303,896 | $539,388 | 30.56 % | $-44,466 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Sangamo Biosciences Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Cell Genesys Inc | CEGE | US | Medical-Biomedical/Gene | 974,295 | Sold Some | -64,792 | -6.23 % | $545,605 | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cell Genesys Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Santarus Inc | SNTS | US | Medical-Drugs | 532,533 | Sold Some | -35,412 | -6.23 % | $1,128,970 | $2,130,132 | $1,001,162 | 88.67 % | $-66,575 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Santarus Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Cytokinetics Inc | CYTK | US | Medical-Biomedical/Gene | 518,964 | Sold Some | -34,502 | -6.23 % | $1,530,944 | $1,764,478 | $233,534 | 15.25 % | $-15,526 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cytokinetics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Pain Therapeutics Inc | PTIE | US | Medical-Drugs | 323,204 | Sold Some | -21,502 | -6.23 % | $1,738,838 | $1,535,219 | $-203,619 | -11.71 % | $13,546 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Pain Therapeutics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Discovery Laboratories Inc | DSCO | US | Therapeutics | 916,990 | Sold Some | -60,970 | -6.23 % | $907,820 | $669,403 | $-238,417 | -26.26 % | $15,852 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Discovery Laboratories Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 875,666 | Sold Some | -68,009 | -7.20 % | $53,152,926 | $43,827,083 | $-9,325,843 | -17.54 % | $724,296 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Genzyme Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Durect Corp | DRRX | US | Medical-Drugs | 760,279 | Sold Some | -50,544 | -6.23 % | $1,953,917 | $1,588,983 | $-364,934 | -18.67 % | $24,261 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Durect Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Regeneron Pharmaceuticals Inc | REGN | US | Medical-Biomedical/Gene | 1,059,335 | Sold Some | -80,243 | -7.04 % | $17,330,721 | $19,555,324 | $2,224,604 | 12.83 % | $-168,510 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Regeneron Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Vivus Inc | VVUS | US | Therapeutics | 519,192 | Sold Some | -58,874 | -10.18 % | $2,876,324 | $4,371,597 | $1,495,273 | 51.98 % | $-169,557 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Vivus Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Viropharma Inc | VPHM | US | Medical-Drugs | 694,676 | Sold Some | -73,793 | -9.60 % | $4,237,524 | $5,349,005 | $1,111,482 | 26.22 % | $-118,069 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Viropharma Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Altus Pharmaceuticals Inc | ALTU | US | Therapeutics | 292,523 | Sold Some | -19,448 | -6.23 % | $125,785 | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Altus Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 721,310 | Sold Some | -53,309 | -6.88 % | $18,314,061 | $20,189,467 | $1,875,406 | 10.24 % | $-138,603 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 788,796 | Sold Some | -23,607 | -2.90 % | $29,358,987 | $34,470,385 | $5,111,398 | 17.40 % | $-152,973 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Gilead Sciences Inc | GILD | US | Therapeutics | 2,913,997 | Sold Some | -231,853 | -7.37 % | $129,905,986 | $135,180,321 | $5,274,335 | 4.06 % | $-419,654 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Gilead Sciences Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Albany Molecular Research Inc | AMRI | US | Research And Development | 361,362 | Sold Some | -25,760 | -6.65 % | $3,241,417 | $2,999,305 | $-242,113 | -7.46 % | $17,259 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Albany Molecular Research Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Optimer Pharmaceuticals Inc | OPTR | US | Medical-Biomedical/Gene | 256,818 | Added More | 34,470 | 15.50 % | $3,577,475 | $3,081,816 | $-495,659 | -13.85 % | $-66,527 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Optimer Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Ariad Pharmaceuticals Inc | ARIA | US | Medical-Biomedical/Gene | 739,861 | Sold Some | -49,192 | -6.23 % | $1,228,169 | $1,598,100 | $369,931 | 30.12 % | $-24,596 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Ariad Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Alkermes Inc | ALKS | US | Drug Delivery Systems | 767,749 | Sold Some | -60,337 | -7.28 % | $6,525,867 | $6,648,706 | $122,840 | 1.88 % | $-9,654 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Alkermes Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Array Biopharma Inc | ARRY | US | Medical-Drugs | 338,576 | Sold Some | -22,516 | -6.23 % | $1,056,357 | $687,309 | $-369,048 | -34.93 % | $24,542 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Array Biopharma Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Orexigen Therapeutics Inc | OREX | US | Medical-Biomedical/Gene | 324,424 | Sold Some | -21,580 | -6.23 % | $1,356,092 | $2,228,793 | $872,701 | 64.35 % | $-58,050 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Orexigen Therapeutics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Acadia Pharmaceuticals Inc | ACAD | US | Medical-Drugs | 359,036 | Sold Some | -23,868 | -6.23 % | $886,819 | $477,518 | $-409,301 | -46.15 % | $27,210 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Acadia Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 816,104 | Added More | 378,490 | 86.48 % | $30,228,492 | $19,260,054 | $-10,968,438 | -36.28 % | $-5,086,906 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Myriad Genetics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Acorda Therapeutics Inc | ACOR | US | Medical-Biomedical/Gene | 343,475 | Sold Some | -28,923 | -7.76 % | $8,916,611 | $8,209,053 | $-707,559 | -7.93 % | $59,581 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Acorda Therapeutics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Osiris Therapeutics Inc | OSIR | US | Therapeutics | 315,534 | Sold Some | -21,209 | -6.29 % | $4,452,185 | $2,073,058 | $-2,379,126 | -53.43 % | $159,916 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Osiris Therapeutics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Adolor Corp | ADLR | US | Medical-Drugs | 718,482 | Sold Some | -47,788 | -6.23 % | $1,487,258 | $1,084,908 | $-402,350 | -27.05 % | $26,761 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Adolor Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Techne Corp | TECH | US | Medical Instruments | 228,382 | Sold Some | -24,514 | -9.69 % | $14,515,960 | $15,329,000 | $813,040 | 5.60 % | $-87,270 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Techne Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Cephalon Inc | CEPH | US | Medical-Drugs | 293,134 | Sold Some | -22,276 | -7.06 % | $16,735,020 | $17,473,718 | $738,698 | 4.41 % | $-56,136 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cephalon Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Medarex Inc | MEDX | US | Therapeutics | 1,650,978 | Sold Some | -129,752 | -7.28 % | $12,266,767 | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Medarex Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Cerus Corp | CERS | US | Medical Products | 306,967 | Sold Some | -20,410 | -6.23 % | $337,664 | $613,934 | $276,270 | 81.81 % | $-18,369 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cerus Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | United Therapeutics Corp | UTHR | US | Therapeutics | 280,676 | Added More | 12,648 | 4.71 % | $23,363,470 | $12,605,159 | $-10,758,311 | -46.04 % | $-484,798 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of United Therapeutics Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 384,177 | Sold Some | -26,253 | -6.39 % | $9,381,602 | $13,419,303 | $4,037,700 | 43.03 % | $-275,919 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Monogram Biosciences Inc | MGRM | US | Medical-Biomedical/Gene | 221,315 | Sold Some | -14,716 | -6.23 % | $444,843 | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Monogram Biosciences Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Avi Biopharma Inc | AVII | US | Therapeutics | 683,880 | Sold Some | -45,474 | -6.23 % | $1,087,369 | $998,465 | $-88,904 | -8.17 % | $5,912 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Avi Biopharma Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Affymetrix Inc | AFFX | US | Medical-Biomedical/Gene | 533,068 | Sold Some | -101,934 | -16.05 % | $3,235,723 | $2,580,049 | $-655,674 | -20.26 % | $125,379 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Affymetrix Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Biomarin Pharmaceutical Inc | BMRN | US | Therapeutics | 1,122,573 | Sold Some | -88,267 | -7.28 % | $15,188,413 | $19,050,064 | $3,861,651 | 25.42 % | $-303,638 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Momenta Pharmaceuticals Inc | MNTA | US | Medical-Biomedical/Gene | 385,193 | Sold Some | -3,508 | -0.90 % | $3,701,705 | $4,256,383 | $554,678 | 14.98 % | $-5,052 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Momenta Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Biomimetic Therapeutics Inc | BMTI | US | Medical-Biomedical/Gene | 193,396 | Sold Some | -12,870 | -6.23 % | $1,796,649 | $2,146,696 | $350,047 | 19.48 % | $-23,295 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biomimetic Therapeutics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Exelixis Inc | EXEL | US | Medical-Biomedical/Gene | 1,290,168 | Sold Some | -103,893 | -7.45 % | $6,425,037 | $8,657,027 | $2,231,991 | 34.73 % | $-179,735 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Exelixis Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Cardiome Pharma Corp | CRME | CA | Medical-Drugs | 544,758 | Sold Some | -36,218 | -6.23 % | $2,070,080 | $2,031,947 | $-38,133 | -1.84 % | $2,535 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cardiome Pharma Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Dendreon Corp | DNDN | US | Therapeutics | 897,577 | Sold Some | -82,553 | -8.42 % | $23,103,632 | $25,141,132 | $2,037,500 | 8.81 % | $-187,395 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Dendreon Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Antigenics Inc | AGEN | US | Therapeutics | 0 | Sold All | -622,270 | -100 % | - | - | - | - % | | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Antigenics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Pozen Inc | POZN | US | Medical-Drugs | 309,151 | Sold Some | -25,660 | -7.66 % | $2,411,378 | $2,148,599 | $-262,778 | -10.89 % | $21,811 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Pozen Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Arena Pharmaceuticals Inc | ARNA | US | Medical-Biomedical/Gene | 550,204 | Sold Some | -36,582 | -6.23 % | $2,167,804 | $1,931,216 | $-236,588 | -10.91 % | $15,730 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Arena Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Alnylam Pharmaceuticals Inc | ALNY | US | Therapeutics | 392,837 | Sold Some | -31,954 | -7.52 % | $8,893,830 | $6,615,375 | $-2,278,455 | -25.61 % | $185,333 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Immunomedics Inc | IMMU | US | Medical-Biomedical/Gene | 794,290 | Sold Some | -52,806 | -6.23 % | $2,025,440 | $2,819,730 | $794,290 | 39.21 % | $-52,806 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Immunomedics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Allos Therapeutics Inc | ALTH | US | Therapeutics | 741,177 | Sold Some | -62,441 | -7.76 % | $5,343,886 | $4,565,650 | $-778,236 | -14.56 % | $65,563 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Allos Therapeutics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Medivation Inc | MDVN | US | Medical-Biomedical/Gene | 281,624 | Sold Some | -27,455 | -8.88 % | $6,305,561 | $8,229,053 | $1,923,492 | 30.50 % | $-187,518 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Medivation Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Nabi Biopharmaceuticals | NABI | US | Therapeutics | 686,862 | Sold Some | -45,682 | -6.23 % | $2,067,455 | $3,365,624 | $1,298,169 | 62.79 % | $-86,339 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-06-05 | 2009-03-31 | N-CSR | Arqule Inc | ARQL | US | Medical-Biomedical/Gene | 344,958 | Sold Some | -22,932 | -6.23 % | $1,886,920 | $1,138,361 | $-748,559 | -39.67 % | $49,762 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Arqule Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Inspire Pharmaceuticals Inc | ISPH | US | Therapeutics | 848,506 | Sold Some | -56,420 | -6.23 % | $4,284,955 | $4,276,470 | $-8,485 | -0.19 % | $564 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Inspire Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Endo Pharmaceuticals Holdings Inc | ENDP | US | Medical-Drugs | 527,627 | Sold Some | -38,284 | -6.76 % | $9,101,566 | $11,713,319 | $2,611,754 | 28.69 % | $-189,506 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Alexza Pharmaceuticals Inc | ALXA | US | Therapeutics | 307,707 | Sold Some | -20,462 | -6.23 % | $544,641 | $701,572 | $156,931 | 28.81 % | $-10,436 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Alexza Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Cubist Pharmaceuticals Inc | CBST | US | Medical-Drugs | 626,722 | Sold Some | -43,264 | -6.45 % | $11,431,409 | $10,622,938 | $-808,471 | -7.07 % | $55,811 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cubist Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Qiagen Nv | QGEN | DE | Medical-Biomedical/Gene | 1,093,941 | Sold Some | -89,049 | -7.52 % | $19,461,210 | $23,530,671 | $4,069,461 | 20.91 % | $-331,262 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Qiagen Nv |
| 2009-06-05 | 2009-03-31 | N-CSR | Gen-Probe Inc | GPRO | US | Diagnostic Equipment | 332,406 | Sold Some | -39,717 | -10.67 % | $14,472,957 | $13,864,654 | $-608,303 | -4.20 % | $72,682 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Gen-Probe Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Luminex Corp | LMNX | US | Medical Products | 389,158 | Sold Some | -34,765 | -8.20 % | $6,389,974 | $5,417,079 | $-972,895 | -15.22 % | $86,913 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Luminex Corp |
| 2009-06-05 | 2009-03-31 | N-CSR | Savient Pharmaceuticals Inc | SVNT | US | Medical-Biomedical/Gene | 484,603 | Sold Some | -32,214 | -6.23 % | $3,489,142 | $6,692,367 | $3,203,226 | 91.80 % | $-212,935 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Savient Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Telik Inc | TELK | US | Medical-Biomedical/Gene | 552,817 | Sold Some | -36,764 | -6.23 % | $608,099 | $431,197 | $-176,901 | -29.09 % | $11,764 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Telik Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Nektar Therapeutics | NKTR | US | Medical-Biomedical/Gene | 1,062,620 | Sold Some | -70,668 | -6.23 % | $7,162,059 | $9,181,037 | $2,018,978 | 28.18 % | $-134,269 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Nektar Therapeutics |
| 2009-06-05 | 2009-03-31 | N-CSR | Theravance Inc | THRX | US | Therapeutics | 525,555 | Sold Some | -29,629 | -5.33 % | $7,252,659 | $7,378,792 | $126,133 | 1.73 % | $-7,111 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Theravance Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Shire Plc | SHPGY | DE | Medical-Drugs | 933,532 | Added More | 441,511 | 89.73 % | $38,881,608 | $52,679,211 | $13,797,603 | 35.48 % | $6,525,533 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Shire Plc |
| 2009-06-05 | 2009-03-31 | N-CSR | Micromet Inc | MITI | DE | Medical-Biomedical/Gene | 100,322 | Added More | 32,726 | 48.41 % | $463,488 | $692,222 | $228,734 | 49.35 % | $74,615 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Micromet Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Osi Pharmaceuticals Inc | OSIP | US | Medical-Drugs | 483,121 | Sold Some | -36,936 | -7.10 % | $14,846,308 | $15,841,538 | $995,229 | 6.70 % | $-76,088 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Osi Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 589,978 | Sold Some | -16,195 | -2.67 % | $7,380,625 | $6,365,863 | $-1,014,762 | -13.74 % | $27,855 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Intermune Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Caliper Life Sciences Inc | CALP | US | Medical Products | 424,745 | Sold Some | -28,236 | -6.23 % | $726,314 | $1,146,812 | $420,498 | 57.89 % | $-27,954 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Caliper Life Sciences Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Zymogenetics Inc | ZGEN | US | Medical-Drugs | 774,979 | Sold Some | -87,547 | -10.15 % | $3,619,152 | $4,587,876 | $968,724 | 26.76 % | $-109,434 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Zymogenetics Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Pdl Biopharma Inc | PDLI | US | Medical-Biomedical/Gene | 1,687,110 | Added More | 775,092 | 84.98 % | $12,079,708 | $13,328,169 | $1,248,461 | 10.33 % | $573,568 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Pdl Biopharma Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Depomed Inc | DEPO | US | Drug Delivery Systems | 537,730 | Sold Some | -48,589 | -8.28 % | $1,473,380 | $1,774,509 | $301,129 | 20.43 % | $-27,210 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Depomed Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 1,057,413 | Sold Some | -63,393 | -5.65 % | $55,112,366 | $49,042,815 | $-6,069,551 | -11.01 % | $363,876 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biogen Idec Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Pharmasset Inc | VRUS | US | Medical-Drugs | 574,438 | Sold Some | -17,481 | -2.95 % | $5,859,268 | $11,293,451 | $5,434,183 | 92.74 % | $-165,370 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Pharmasset Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Matrixx Initiatives Inc | MTXX | US | Drug Delivery Systems | 78,572 | Sold Some | -16,999 | -17.78 % | $1,530,583 | $331,574 | $-1,199,009 | -78.33 % | $259,405 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Matrixx Initiatives Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Xenoport Inc | XNPT | US | Medical-Drugs | 258,124 | Sold Some | -6,294 | -2.38 % | $5,418,023 | $4,220,327 | $-1,197,695 | -22.10 % | $29,204 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Xenoport Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Idenix Pharmaceuticals Inc | IDIX | US | Medical-Drugs | 528,537 | Sold Some | -35,152 | -6.23 % | $1,812,882 | $972,508 | $-840,374 | -46.35 % | $55,892 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Idenix Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Xoma Ltd | XOMA | US | Medical-Biomedical/Gene | 1,868,714 | Sold Some | -124,254 | -6.23 % | $1,980,837 | $1,382,848 | $-597,988 | -30.18 % | $39,761 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Xoma Ltd |
| 2009-06-05 | 2009-03-31 | N-CSR | Medicines Cothe | MDCO | US | Therapeutics | 350,389 | Sold Some | -28,550 | -7.53 % | $2,533,312 | $2,620,910 | $87,597 | 3.45 % | $-7,138 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Medicines Cothe |
| 2009-06-05 | 2009-03-31 | N-CSR | Biocryst Pharmaceuticals Inc | BCRX | US | Medical-Biomedical/Gene | 350,273 | Sold Some | -23,296 | -6.23 % | $1,464,141 | $3,345,107 | $1,880,966 | 128.46 % | $-125,100 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Akorn Inc | AKRX | US | Medical-Drugs | 892,929 | Sold Some | -59,384 | -6.23 % | $919,717 | $1,437,616 | $517,899 | 56.31 % | $-34,443 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Akorn Inc |